Trial intelligence / Profile preview

Pyrotinib + capecitabine vs lapatinib + capecitabine in HER2-positive metastatic breast cancer

CTR20150279Phase 3Active

Sponsor

Hengrui Therapeutics

Start

Jun 2015

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1